Página 3 - Melhores Mamografia médicos - TOP-144 médicos

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Univ.-Prof. Dr. Wolfgang Johannes Köstler is a board-certified specialist for Internal Medicine, Hematology/Oncology, and Intensive Care Medicine who specializes in hematology & internal oncology, intensive care medicine. He is one of the top-rated breast cancer and sarcoma oncologist specialists and has extensive experience in the field and has received degrees from the Medical University of Vienna and the Weizmann Institute of Science. He has also had special training at Memorial Sloan-Kettering Cancer Center and Royal Prince Alfred Hospital.

• Education
• 1992-1999 - Faculty of Medicine, Technion.
• Specialization
• 2000-2005 - Internship, Institute of Visualization, Tel Aviv Sourasky Medical Center (Ichilov).
• Recognized experience
• Diagnostic radiology
• Subspecialization:
• 2005-2007 - Breast imaging, Mammography Institute, Tel Aviv Medical Center.
• Additional education
• 2008 - MRI of the mammary gland, internship at the Medical Center of the Curie Institute, Paris, France.
• 2012 - Training period in advanced breast imaging technologies at the Gustave Roussy Cancer Center, Villejuif, France.
• 2009,2011,2013 - Updated courses on breast visualization.
• Clinical experience
• 2013 - Director of the Mammography Department, Tel Aviv Medical Center.
• 2007 - Maccabi HMO Breast Imaging Consultant.
• 2005 - Senior Physician, Sourasky Medical Center, Tel Aviv.
• 2000-2005 - Internship, Institute of Visualization, Sourasky Medical Center, Tel Aviv.
• 1999-2000 - Internship, Sheba Medical Center.
• Academic experience
• 2010- Breast imaging training for medical students in clinical years, Department of Imaging, Faculty of Medicine, Tel Aviv University
• 2013 - Lecturer for surgical interns, School of Continuing Education, School of Medicine, Tel Aviv University.
• 2000-2005 - Lecturer in Visualization at the School of Radiography, Sourasky Medical Center, Tel Aviv, Bar-Ilan University.
• Trade union membership
• Israel Association of Radiologists
• Breast Imaging Department
• Israel Medical Association
• North American Society of Radiology.
• Areas of special interest and activities
• Breast biopsy and preoperative MRI-guided marking.
• Breast visualization in automated 3D ultrasound.
• Removal of breast lumps using non-invasive radiofrequency technology (BLES).
• Mammography with the introduction of a contrast agent.
• Molecular Breast Imaging, MBI (Molecular Breast Imaging)

PLOYPAILIN RATTANACHINNAKORN, M.D.

Plastic and Reconstructive Surgeon

Graduated (M.D. From)
Doctor of Medicine, Faculty of Medicine, Chulalongkorn University

Certificates

Certificate of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University

Certificate of specialty in Plastic and Maxillofacial Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University

Certificate for Doctors Training Program at the 2024 KVPS (Korea V Plastic Surgery Symposium), Demonstrating Excellence in Facelift with Masters Course.

Work History (Experiences)

Member of the Medical Council of Thailand (Memberships)

Member of the Royal College of Surgeons of Thailand

Current Positions

PLASTIC AND RECONSTRUCTIVE SURGEON AT INTRARAT HOSPITAL

Dr. Florian Fitzal is a senior physician at Vienna General Hospital and Vienna Medical University. He specializes in breast and abdominal surgery. He is a certified surgeon and holds a Master of Public Health (MBA). Dr. Fitzal leads the Breast Health Center. He also serves as Scientific Director of the Surgical Center of the Breast.

He is an auditor for the European Council of Surgeons. He is also a board member of the Austrian Breast Cancer and Colorectal Cancer Research Group. Dr. Fitzal has published over 143 scientific papers and has an h-index of 24. He has written four books on breast cancer surgery. He is known for his work in breast-conserving, oncoplastic, and reconstructive surgery.

Specializations

• Rhinoplasty Aesthetics
• Facial Applications in Surgery
• Breast Aesthetics
• Body Shaping Aesthetics
• Liposuction
• Botox-Filler-Mesotherapy Procedures

Dra. Viola Fox é a Médica Chefe da Clínica de Hematologia, Oncologia e Medicina Paliativa no BKZ Solingen. Esta clínica é um centro de câncer interdisciplinar certificado. A Dra. Fox é uma especialista de destaque em terapia medicamentosa para doenças tumorais na Alemanha e na Europa. Ela tem mais de 15 anos de experiência nesta área.

Ela é membro da Sociedade Alemã de Oncologia e Hemato-oncologia (GDHO), da Associação Alemã de Médicos e da American Association for Cancer Research. A Dra. Fox também é ativa na pesquisa em biologia molecular. Seu trabalho apoia o progresso no tratamento do câncer e nos diagnósticos moleculares.

As suas principais áreas de especialização são a quimioterapia, a imunoterapia, a terapia alvo e a radioterapia. A Dra. Fox é conhecida por seus métodos inovadores e forte compromisso com o cuidado ao paciente. Seus esforços levaram a altas taxas de recuperação e reconhecimento de seus pares.

A Dra. Séverine Iborra é a Médica Chefe do Departamento de Ginecologia e Obstetrícia do Städtisches Klinikum Solingen. Suas responsabilidades incluem obstetrícia, a sala de parto, a unidade neonatal e ginecologia. O departamento também inclui a Clínica de Senologia/Mama no Centro de Mama Bergisches Solingen, liderada pela Dra. Manuela Seifert.

A Dra. Séverine Iborra é originária da França. Ela iniciou seus estudos de medicina na Universidade de Lyon e, posteriormente, transferiu-se para a Universidade Albert-Ludwigs em Freiburg, onde obteve sua licença médica em 2007. Ela obteve seu doutorado em 2008 por meio de pesquisa experimental em oncologia molecular. De agosto de 2008 a novembro de 2013, a Dra. Iborra trabalhou como residente na Clínica Universitária de Mulheres em Freiburg. Após passar nos exames de especialista em ginecologia e obstetrícia, continuou sua carreira como especialista na mesma clínica. Em novembro de 2015, ela transferiu-se para o Hospital Universitário RWTH Aachen como médica sênior.

Na Clínica de Ginecologia e Obstetrícia, sob a liderança do Prof. Dr. E. Stickeler, a Dra. Iborra liderou o departamento de obstetrícia de 2017 a 2019. Desde dezembro de 2017, foi responsável pela organização do ensino no departamento, e em outubro de 2019, tornou-se Médica Sênior Gerente e Médica Sênior de Pessoal da clínica, posição que ocupou até se mudar para Solingen.

Além de seu trabalho científico, com inúmeras publicações e apresentações em grandes conferências ginecológicas, a Dra. Iborra aprofundou suas especialidades médicas. Ela obteve certificações em diagnóstico e terapia oncológica do Grupo de Trabalho de Oncologia Ginecológica, bem como qualificações adicionais em Patologia Cervical e Colposcopia (AGCPC), Uroginecologia e Cirurgia Reconstrutiva Pélvica (AGUP), e da Associação Profissional de Ginecologistas (BVF).

Em 2019, a Dra. Iborra concluiu com sucesso uma especialização adicional em “Oncologia Ginecológica” e “Obstetrícia Especial e Medicina Perinatal.” Ela é membro ativo de importantes sociedades médicas alemãs em sua área, incluindo a Sociedade Alemã de Ginecologia e Obstetrícia, o Grupo de Trabalho de Patologia Cervical e Colposcopia, e a Sociedade Alemã de Medicina Pré-Natal e do Parto.

Tratamentos Oferecidos em Nosso Departamento de Ginecologia

• Histeroscopia e Dilatação e Curetagem (D&C) para fins diagnósticos e terapêuticos.
• Remoção de achados ovarianos anormais ou sintomáticos, como cistos, preservando o restante do ovário.
• Ooforectomia (remoção de ovários) em casos de anomalias ou preventivamente quando indicado.
• Miomectomia (remoção de miomas uterinos) preservando o útero.
• Tratamento conservador de miomas: seja medicamentoso ou embolização realizada por especialistas em radiologia.
• Histerectomia com ou sem remoção do colo do útero.
• Diagnóstico e esclarecimento de achados incertos no colo do útero, vagina e vulva.
• Tratamento de displasia.
• Tratamento da endometriose.
• Tratamento do câncer para câncer de vulva, vagina, colo do útero, útero e ovário.
• Tratamento para incontinência e/ou prolapso dos órgãos pélvicos.

Sempre que possível, oferecemos todos os procedimentos como tratamentos minimamente invasivos usando laparoscopia ou o sistema robótico Da Vinci.

Lee Ji Hyun, MD, is a breast and thyroid surgeon. Dr. Lee is Head of Breast and Thyroid Surgery at Naeun Hospital. Clinical focus includes benign breast disease, breast cancer, and tumor surgery. Additional areas include benign thyroid disease, thyroid cancer, and parathyroid disorders. Skills include Mammotome procedures, axillary node management, and breast and thyroid ultrasound.

Education and training: Yonsei University College of Medicine. Internship and general surgery residency at Yonsei University Severance Hospital. Short-term clinical training at the Affiliated Hospital of the Cancer Research Institute in Japan.

Key roles: Chief of General Surgery at Incheon Christian Hospital and General Surgery Specialist at Cheil Hospital. Director of the Breast Center and Chief of the Department of Surgery at Samsung Cheil Hospital. Chief of General Surgery and Deputy Director of Clinical Services at Cheil Hospital. Outpatient Professor of Surgery at CHA Gangnam Medical Center, CHA University. Chief of General Surgery at Daejeong Hospital.

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Education & Expertise

• 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Düzce University, Internal Medicine Specialization
• 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
• 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
• 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
• 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
• 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
• 2020 to Present – Professor, Sakarya University Faculty of Medicine
• 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

• 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
• 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

• TTOD (Turkish Society of Medical Oncology)
• ASCO (American Society of Clinical Oncology)
• ESMO (European Society for Medical Oncology)

CANER GELBAL, MD

Birth Date : January 16, 1993 year

Birth Place : İstanbul, Turkey

Education, Awards and Certifications

• Inter High School Olympic Competition,Ankara Science High School Olympic Team Captain,Scientific and Technological Research Council of Turkey(TUBİTAK)-2009 year
• Ankara Science High School-2007-2010 year
• İzmir Science High School – 2010-2011 year 
• Istanbul University School of Medicine – 2017 year 
• Animal Research Certificate – January 2019 year 
• Microsurgery Certificate- May 2019 year 
• Bagcilar Research and Training Hospital , Department  of Plastic,Reconstructive and Aesthetic Surgery  - 2018 year – Current
   

Rotations

November 2018 year - April 2019 year  - General Surgery Rotation - Bagcilar Research and Training Hospital Department of General Surgery

April - May 2019 year - Orthopedia Rotation - Bagcilar Research and Training Hospital Department of Orthopedia

Articles published in nationally-respected journals: 

1. Tatar BE, Gelbal C, Sezgiç M, Karakol P, Uslu C, Kabul S. A Rare Case: Malignant Granular Cell Tumor in Axillary Region.

Oral Presentations in International Meetings

1.Using Mandibular Bony Tissues Which Are Treated with Liquid Nitrogen As Scaffold For Partial Femoral Transplantation in Mandible Reconstruction and Evaluation of Bone Survival: Experimental Rat Femur Transplantation Model 

Percin Karakol, Burak Ergün Tatar, Can Uslu, Caner Gelbal, Mehmet Bozkurt 

11th European Plastic Surgery Research Council August 23-25, 2018 year, Munich, Germany

2. The Effect of Centrifuge Duration on Fat Graft Survival 

Percin Karakol, Burak Ergün Tatar, Can Uslu, Caner Gelbal, Mehmet Bozkurt

11th European Plastic Surgery Research Council August 23-25, 2018 year, Munich, Germany

3. Are the permanent effects of renal failure not so permanent? 

Percin Karakol, Caner Gelbal, Can Uslu, Burak Ergün Tatar, Mehmet Bozkurt

11th European Plastic Surgery Research Council August 23-25, 2018 year, Munich, Germany

Oral Presentations in national Meetings:

1.Üst ekstremite acil ve elektif vakalarda WALANT’ın kullanımı.                                   

Burak Ergün Tatar, Perçin Karakol, Can Uslu, Caner Gelbal  41. Ulusal Plastik Cerrahi Kurultayı, 26-30 October, 2019 year, Samsun,Turkey

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

• Completion of the degree at the FACULTY OF MEDICINE OF THE AUTONOMOUS UNIVERSITY OF MADRID (UAM) during the academic years 1975-76 to 1980-81, obtaining the title of Bachelor of Medicine and Surgery at the said University in JUNE 1981.
• A full-time student at the Department of Physiology, Faculty of Medicine, U.A.M., in the summers of 1977, 79, 80 and 81, he participated in various research projects and acquired basic knowledge in the field of fundamental research.

SPECIALTIES:

- Medical specialist in INTENSIVE CARE MEDICINE.

- Receiving position number 96 in the MIR call November 1981.

- Resident physician assigned to the Intensive Care Service of the Ramón y Cajal Hospital in Madrid from 1982 to 1986 (5 years) to develop a program in this specialty.

- Member of the Spanish Society of Intensive Medicine and Coronary Units (SEMIUC).

- Member of the editorial board of the EMERGENCIAS magazine.

- General practitioner assigned to the Department of Plastic and Reconstructive Surgery at the Hospital "Doce de Octubre" in Madrid, from April 1989 to December 1993. (5 years).

- Multiple member (No. 361) of the SPANISH SOCIETY OF REPARATIVE AND AESTHETIC PLASTIC SURGERY (SECPRE).

- Receiving FIRST PRIZE in the competition of resident doctors at the VI meeting of SECPRE in Granada, November 1992.

- Director of the International Symposium on Breast Reconstruction. Hospital 12 Octubre INSALUD, Madrid, 13, 14 and 15 November 1996.

- Representative member of the SPANISH SOCIETY OF RECONSTRUCTIVE AND AESTHETIC PLASTIC SURGERY to the EUROPEAN UNION OF MEDICAL SPECIALISTS (UEMS), from December 1994 to December 2000.

- Member of EBOPRAS (European Board of Plastic Reconstructive and Aesthetic Surgery) from December 1994 to December 2000.

- Vice-Secretary of the Spanish Society of Plastic, Reconstructive and Aesthetic Surgery (SECPRE). Between 1997 and 1998.

- SECRETARY GENERAL of the Spanish Society of Reconstructive and Aesthetic Plastic Surgery (SECPRE), from January 1999 to December 2000.

- Delegate of Spanish plastic surgeons to the International Plastic, Reconstructive and Aesthetic Surgery (IPRAS). During 2000.

- Secretary General of the SECPRE Training Foundation. During 2001 and 2002.

- Member of the National Commission of Plastic and Reconstructive Surgery, representing the Spanish Society of Plastic, Reconstructive and Aesthetic Surgery, from June 2000 to May 2004.

- Director of the II SYMPOSIUM: Breast Implants in Plastic Surgery. January 25-26, 2002.

- Co-director of the annual training course on augmentation mammoplasty 2004, held at the Monteprincipe Hospital in Madrid.

- Co-director of the annual training course on augmentation mammoplasty 2005, held at the Teknon Clinic in Barcelona.

- Member of the Spanish Society of Anti-Aging and Longevity Medicine.

PLASTIC SURGERY

1. Assistant surgeon to Dr. ANTONIO DE LA FUENTE GONZALEZ in the practice of plastic and aesthetic surgery from October 1989 to November 1993.

2. Conducting the IX PRACTICAL COURSE OF EXPERIMENTAL MICROSURGERY, at the ASEPEYO MONOGRAPHIC HOSPITAL, November 1989.

3. Periodic assistance to the Experimental Surgery Service of the Ramon y Cajal Center in Madrid for EXPERIMENTAL MICROSURGERY on rats from January 1990 to January 1995.

4. Assistance to the plastic surgery service of the Villa Salaria clinic in Rome (Italy) under the direction of Dr. M. Gasparotti in teaching the surgical technique of SUPERFICIAL LIPOSUCTION. December 1992.

5. Attendance at the CANNIESBERN FLAP COURSE, Canniesburn Hospital, Glasgow, England, March 1993.

6. Attendance at the 10th INTERNATIONAL COURSE IN PLASTIC AND AESTHETIC SURGERY at the Planas Clinic, Barcelona, June 1993.

7. Participation in the 1st SYMPOSIUM ON ADVANCES IN BREAST RECONSTRUCTION. Nashville. USA. Tennessee. May. 1995.

8. Attendance at the INTERNATIONAL COURSE IN PLASTIC-AESTHETIC SURGERY at the Planas Clinic. Barcelona. June 1996.

TEACHING ACTIVITIES

- PROFESSOR of Nursing at the SALUS INFIRMORUM School of Nursing (Madrid School) of the Pontifical University of Salamanca from 1984 to 1992.

- PROFESSOR of the Emergency Surgery Course of the Special Emergency Service (INSALUD). Madrid, 3–7 June 1991.

- PROFESSOR of the specialized course "OUT-OF-HOSPITAL MEDICAL EMERGENCY" of the FACULTY OF MEDICINE OF THE COMPLUTENS UNIVERSITY OF MADRID under the direction of Professor Dr. F. Martin Santos. 1989-90 academic year.

- PROFESSOR of the Primary Care Surgery Course. Virgen de la Torre Hospital. Organizer: College of Physicians of Madrid and the Department of Health of the Community of Madrid. Madrid, June 1990.

- PROFESSOR of the Department of Surgical Pathology of Plastic and Reconstructive Surgery of the School of Nursing SALUS INFIRMORUM (Madrid School) of the Pontifical University of Salamanca from October 1992 to the present.

- TEACHER of the course "TRAUMATIC INJURIES OF THE CRANIAL ROD AND POSTERIOR SKIN". ASEPEYO, November 1993.

- PROFESSOR of the doctoral course "Behavioural Neurobiology" under the direction of Dr. R. García Cordovilla. Faculty of Science. Biology. Complutense University. Madrid. (1994-95, 1995-96, 1997-98 and 1998-99 academic years).

- Associate teacher of practical classes in surgical pathology at the Faculty of Medicine of the Complutense University of Madrid.

- Author of the topic "Soft tissue tumors" in the edition of the Curriculum of the specialty "Plastic and reconstructive surgery" of the Spanish Society of Plastic, Reconstructive and Aesthetic Surgery. Edition of 1997.

Other experience

- DEPUTY CHIEF PHYSICIAN of the regional party Campo Real, Madrid, August 1981.

- Doctor of the company "EUROPE ASSISTANCE" from January 1984 to January 1989, holding the position of MEDICAL DIRECTOR, and also carrying out the transportation and repatriation of patients in critical condition.

- RESIDENT PHYSICIAN in intensive care medicine, who worked in the Intensive Care Unit of the Ramón y Cajal Hospital in Madrid from 1982 to 1986.

- ASSISTANT PHYSICIAN in the Intensive Care Unit of the Ramón y Cajal Hospital in Madrid in 1987.

- REGIONAL SPECIALIST FACULTY of the Intensive Care Service of the Alcalá de Henares Hospital from January 1988 to April 1989.

- RESIDENT PHYSICIAN in the specialty of plastic and reconstructive surgery, assigned to the service in the said specialty at the "Doce de Octubre" hospital from April 1989 to December 1993.

- Surgeon in the Department of Plastic and Aesthetic Surgery at HOSPITAL RUBER INTERNACIONAL under the direction of Dr. Antonio de la Fuente from January 1991 to November 1993.

- Surgeon in the Department of Plastic and Reconstructive Surgery at the HOSPITAL MONOGRAFICO ASEPEYO in Coslada (Madrid) from January 1992 to November 1993.

- REGIONAL FACULTY SPECIALIST in PLASTIC AND RECONSTRUCTIVE SURGERY at the 12 OCTOBER INSALUD HOSPITAL, Madrid, from January 1994 to May 2001.

- Private practice of reconstructive and aesthetic plastic surgery as Director of the Martin del Hierro Institute of Plastic Surgery, C/ General Ampudia, No. 6, 28003 Madrid.

- Private practice of reconstructive and aesthetic plastic surgery as team leader at LA LUZ CLINIC. Calle del Maestro Angel Lorca, 8. Madrid.

- Private practice of plastic, reconstructive and aesthetic surgery as Head of the Plastic Surgery Department of the MONTEPRINCIPE Hospital in Madrid.

PUBLICATIONS

45 papers for national and international conferences

40 publications in national and international journals

37 courses and symposia were held

Oncologist, specialist in gastrointestinal cancer treatment

Education
1991 to 1997 Istanbul University Cerrahpaşa Faculty of Medicine
1998 to 2003 Ministry of Health Göztepe Training and Research Hospital

Experience
1997 to 1998 Van Edremit Health Center
1998 to 2003 Ministry of Health Göztepe Training and Research Hospital, Resident Doctor
2004 to 2007 Sivas State Hospital, General Surgery Clinic, Specialist Doctor
2007 to Present Medical Park Bahçelievler Hospital, Associate Professor

Professional Memberships
-Turkish Medical Association
-Turkish Surgical Society
-Society of Bariatric and Metabolic Surgery
-Turkish Society of Colon and Rectal Surgery
-Society of Endocrine Surgery

Dr. Zuhal Cakmak Peksen is a Family Medicine Specialist since 2017. She earned her MD from Çukurova University in 2010. She completed specialty training at Yüzüncü Yıl University between 2013 and 2017. She is currently studying for a bachelor’s degree in Health Management at Anadolu University (2024–present).

She has 15 years of clinical practice (2010–2025) across 8 institutions. Her experience includes research in Family Medicine (2013–2017) and work at several Family Health Centers. Since 2020, she has served at TOKİ Avrupa Family Health Center in Gaziosmanpaşa, Istanbul.